Trulieve CEO: Medical Cannabis Transition | Mad Money | CNBC
It’s a medical marijuana company helping over 80,000 patients and you may have never heard of it. Jim Cramer looks into Trulieve and what it can tell us about the…
ETF Spotlight: Aurora cannabis hit by pandemic-related restrictions
CNBC’s Morgan Brennan takes a look at cannabis-focused ETFs and the dip in Aurora shares. For access to live and exclusive video from CNBC subscribe to CNBC PRO: Subscribe to…
Cannabis stocks in 2022: Top trends for investors to watch
Amplify Seymour Cannabis ETF (CNBS) portfolio manager Tim Seymour walks investors through the top trends to watch in the marijuana space in 2022 and beyond. For access to live and…
Canopy Growth CEO on cannabis sell-off
Bruce Linton, Canopy Growth CEO, discusses the volatile moves in cannabis stocks just a week after Canada legalized recreational marijuana use.
Amount of cannabis seized at UK airports triples in less than year
The amount of cannabis seized at airports in suitcases has tripled in less than a year, officials have said. The National Crime Agency has said the surge is being driven…
GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC
Canada’s marijuana legalization may be all the rage, but one drug company has been working for years to create real cannabis-based medicine. Jim Cramer hears from GW Pharma’s CEO about…
How midterm elections could impact the cannabis business
Vivien Azer, Cowen senior research analyst, and CNBC’s Aditi Roy join ‘Squawk Alley’ to discuss how cannabis regulation could be affected by the midterm elections, specifically in Utah, North Dakota,…
Cannabis stocks bounce with legalization in focus — What Tim Seymour’s watching
Tim Seymour, portfolio manager of the Amplify Seymour Cannabis ETF (CNBS) and a CNBC contributor, breaks down what to watch after a huge comeback in cannabis stocks. For access to…
Cannabis reclassification is ‘a real milestone’ for the industry,” says Curaleaf’s Boris Jordan
Boris Jordan, co-founder and executive chairman of Curaleaf, joins ‘Squawk on the Street’ to discuss the significance of cannabis’ reclassification, the federal tax code around cannabis, and much more.
U.S. vs. Canadian cannabis stocks: Key distinctions
Tim Seymour, who runs the Amplify Seymour Cannabis ETF (CNBS), explains the performance discrepancy between U.S. and Canadian pot stocks around U.S. elections. For access to live and exclusive video…